Get started
Author

Maggie Rostron

Observed name: M. Rostron
ORCID: 0009-0008-8049-8414
Observed ORCID: 0009-0008-8049-8414
OpenAlex ID: A5035406437
Lorundrostat in Participants With Uncontrolled Hypertension and Treatment-Resistant Hypertension
2025 · Manish Saxena, Luke Laffin, et al. · JAMA · 109
PDF
Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension
2025 · Akshay S. Desai, Adam D. Karns, et al. · JAMA · 45
Survey and Evaluation of Hypertension Machine Learning Research
2023 · Clea du Toit, Tran Quoc Bao Tran, et al. · Journal of the American Heart Association · 20
PDF
The impact of renal artery stenting on therapeutic aims
2022 · Ben Edgar, Robert Pearson, et al. · Journal of Human Hypertension · 6
PDF
A novel index for measuring the impact of devices on hypertension
2023 · D. B. Kingsmore, B. Edgar, et al. · Scientific Reports · 3
PDF
OPTIMA-BP: empOwering PaTients in MAnaging Blood Pressure – protocol for a randomised parallel group study comparing use of Kvatchii web-based patient education portal as an addition to home blood pressure monitoring
2024 · Linsay McCallum, Stefanie Lip, et al. · Open Heart · 2
PDF
Investigating the Quality of Machine Learning Research and Reporting in Hypertension
2022 · Clea Du Toit, Tran Tran, et al. · Journal of Hypertension · 2
Correction: The impact of renal artery stenting on therapeutic aims
2024 · Ben Edgar, Robert Pearson, et al. · Journal of Human Hypertension
PDF
Abstract P259: Cardiovascular Pharmacotherapy And Covid-19
2021 · Stefanie Lip, Linsay McCallum, et al. · Hypertension
Abstract P265: Hypertension, Vascular Dysfunction And Downregulation Of The Renin Angiotensin System Sequelae Of COVID-19
2021 · Linsay McCallum, Stefanie Lip, et al. · Hypertension
Works count: 10
Citation count: 187
H-index: 4
I10-index: 3
Year
Topic
Type